Science Explorer Back to mapMap
Discussion
Topic · Oncology

CAR-T cell therapy research

CAR-T cell therapy research is a research topic within Oncology. Science Explorer counts 48k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on Chimeric Antigen Receptor (CAR) T cell therapy, a form of immunotherapy that uses genetically engineered T cells to target and destroy cancer cells. The papers cover various aspects of CAR T cell therapy, including its application in treating leukemia, lymphoma, and solid tumors, the management of cytokine release syndrome associated with this therapy, and the long-term efficacy and safety of CAR T cell treatment.

  • CAR T Cells
  • Chimeric Antigen Receptor
  • T Cell Therapy
  • Leukemia
  • Lymphoma
  • Immunotherapy
  • Cytokine Release Syndrome
  • Tumor Regression
  • Adoptive Cell Transfer
  • Cancer Immunotherapy
Research works
48k
fractional, since 1950
In the world top 10%
4.9k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+53%
the tick is no change
Largest producer
United States
49% of the 10 largest, 2022-now
Drawing this view